AU2206499A - Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions - Google Patents
Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditionsInfo
- Publication number
- AU2206499A AU2206499A AU22064/99A AU2206499A AU2206499A AU 2206499 A AU2206499 A AU 2206499A AU 22064/99 A AU22064/99 A AU 22064/99A AU 2206499 A AU2206499 A AU 2206499A AU 2206499 A AU2206499 A AU 2206499A
- Authority
- AU
- Australia
- Prior art keywords
- myopia
- conditions
- various
- treat glaucoma
- muscarinic agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6862697P | 1997-12-23 | 1997-12-23 | |
| US60068626 | 1997-12-23 | ||
| PCT/US1998/027586 WO1999032443A1 (en) | 1997-12-23 | 1998-12-22 | Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2206499A true AU2206499A (en) | 1999-07-12 |
Family
ID=22083734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU22064/99A Abandoned AU2206499A (en) | 1997-12-23 | 1998-12-22 | Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2206499A (en) |
| WO (1) | WO1999032443A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020205867A1 (en) | 2019-04-02 | 2020-10-08 | Aligos Therapeutics, Inc. | Compounds targeting prmt5 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR73633B (en) * | 1980-03-10 | 1984-03-26 | Janssen Pharmaceutica Nv | |
| GB9121631D0 (en) * | 1991-10-11 | 1991-11-27 | Nat Res Dev | Pharmaceutical compositions |
| US5691323A (en) * | 1995-05-12 | 1997-11-25 | Merck & Co., Inc. | Muscarine antagonists |
| DE19607436A1 (en) * | 1996-02-28 | 1997-09-04 | Thomae Gmbh Dr K | New carboxylic acid compounds useful e.g. as antiinflammatory or antithrombotic agents |
-
1998
- 1998-12-22 AU AU22064/99A patent/AU2206499A/en not_active Abandoned
- 1998-12-22 WO PCT/US1998/027586 patent/WO1999032443A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999032443A1 (en) | 1999-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2307999A (en) | Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions | |
| AU2206699A (en) | Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions | |
| AU2111199A (en) | Benzenesulfonamides and benzamides as therapeutic agents | |
| AU3185495A (en) | Spiro-substituted azacyclic derivatives and their use as therapeutic agents | |
| AU4520697A (en) | Use of substituted benzazoles as UV absorbers, new benzazoles and processes for their preparation | |
| AU3102097A (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
| AU3497295A (en) | Compositions and methods for the treatment of body weight disorders, including obesity | |
| AU1709699A (en) | 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension | |
| AU4069395A (en) | Optically active benzothiepin derivative, its preparation and use | |
| WO1998039293A3 (en) | 13-thia prostaglandins for use in glaucoma therapy | |
| HK1001286A1 (en) | Benzopyrans and their use as therapeutic agents. | |
| AU8038998A (en) | Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters | |
| AU2307899A (en) | Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions | |
| AU3651795A (en) | Substituted pyrazolyl-pyrazole derivatives, processes for their preparation and their use as agents with herbicidal action | |
| AU3268197A (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
| AU1714599A (en) | Treatment of glc1a glaucoma with glucocorticoid antagonists | |
| AU1249395A (en) | Topical treatment of ocular photophobia | |
| AU6714996A (en) | 2-(fluorenonyl)-carbapenems, compositions and methods of use | |
| AU2068295A (en) | Skin treatment composition | |
| AU2206499A (en) | Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions | |
| AU2306595A (en) | Dihydrodibenzo(de,h)isoquinolines derivatives and their use as anti-cancer agents | |
| AU7759698A (en) | Hair treatment agents | |
| AU2434297A (en) | The use of 5-ht1b/1d agonists to treat ocular pain | |
| AU8799398A (en) | Physiological combination of active substances to enhance the skin's defenses against noxious agents | |
| AU3061199A (en) | Skin treatment compositions and the use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |